Efficacy and safety of caspofungin in critically ill patients. ProCAS Study.
León-Gil C, Ubeda-Iglesias A, Loza-Vázquez A, de la Torre MV, Raurich-Puigdevall JM, Alvarez-Sánchez B, Ortiz-Leyva C, Domínguez-Roldán JM, Socías-Crespi L, Garnacho-Montero J; ProCAS Study Group.
León-Gil C, et al.
Rev Esp Quimioter. 2012 Dec;25(4):274-82.
Rev Esp Quimioter. 2012.
PMID: 23303260
Free article.
Clinical Trial.